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Most colicins kill Escherichia coli cells by membrane pore formation or nuclease activity and,
superficially, the mechanisms are similar: receptor binding, translocon recruitment, periplasmic
receptor binding and membrane insertion. However, in detail, they employ a wide variety of
molecular interactions that reveal a high degree of evolutionary diversification. Group A colicins
bind to members of the TolQRAB complex in the periplasm and heterotrimeric complexes of
colicin–TolA–TolB have been observed for both ColA and ColE9. ColN, the smallest and simplest
pore-forming colicin, binds only to TolA and we show here that it uses the binding site normally
used by TolB, effectively preventing formation of the larger complex used by other colicins. ColN
binding to TolA was by b-strand addition with a KD of 1 mM compared with 40 mM for the TolA–
TolB interaction. The b-strand addition and ColN activity could be abolished by single proline
point mutations in TolA, which each removed one backbone hydrogen bond. By also blocking
TolA–TolB binding these point mutations conferred a complete tol phenotype which destabilized
the outer membrane, prevented both ColA and ColE9 activity, and abolished phage protein
binding to TolA. These are the only point mutations known to have such pleiotropic effects and
showed that the TolA–TolB b-strand addition is essential for Tol function. The formation of this
simple binary ColN–TolA complex provided yet more evidence of a distinct translocation route for
ColN and may help to explain the unique toxicity of its N-terminal domain.
INTRODUCTION
Colicins are plasmid-encoded bacteriocins secreted by
Escherichia coli which kill closely related competing bacte-
ria by penetrating their outer membranes and delivering
a toxic domain into or beyond the inner membrane
(Cascales et al., 2007). Initially, they bind a cell surface
receptor, after which they recruit a translocator protein to
cross the outer membrane. Colicins are classified into
Group A or B according to the periplasmic proteins they
use for translocation. Group B uses the Ton system, whilst
Group A utilizes the Tol proteins Q, R, A and B, and
includes ColA, ColN, ColE1–9 and ColK (Kim et al., 2014).
TolA is a 421-residue protein (Levengood & Webster,
1989) consisting of three domains: TolAI, TolAII and
TolAIII. TolAI is a transmembrane helix, anchored to the
inner membrane, which interacts with TolQ and TolR
(Derouiche et al., 1995), whilst TolAII is a 250-residue
helical region with an opaque role in colicin function
(Schendel et al., 1997). TolAIII is involved in a range of
protein–protein interactions (Kim et al., 2014). TolA has
an important role in outer membrane integrity (Fognini-
Lefebvre et al., 1987; Webster, 1991) and is also involved in
the import of filamentous bacteriophage DNA (Click &
Webster, 1998; Webster, 1991). TolB is a 47 kDa two-
domain soluble protein which interacts both with TolAIII
and via a high-affinity interaction with the outer-
membrane-bound, peptidoglycan-associated lipoprotein
Pal (Abergel et al., 1999; Bonsor et al., 2009; Bouveret
et al., 1995). DTol mutants are able to replicate, but
members of the Tol complex move to the central division
zone during cell division, implying a non-essential role in
this process (Gerding et al., 2007).
One emerging characteristic of colicin biology is that
although the general mechanisms are similar, there is an
astonishing variation in the specific molecular interactions
employed by different colicins (Grinter et al., 2014; Jakes,
2014; Kleanthous, 2010). ColA and ColN are Group A
pore-forming colicins and cell killing is via formation of
an ion channel in the inner membrane (Baty et al., 1990).
ColA and ColN comprise three distinct domains having
roles in each of the three insertion steps. ColN, uniquely,
Abbreviations: ColA-R, receptor-binding domain of colicin A; ColA-T, T
domain of colicin A; ColN-R, receptor-binding domain of colicin N; ColN-
T, T domain of colicin N; CD, circular dichroism; GTS, glutathione S-
transferase; ITC, isothermal titration calorimetry; PDB, Protein Data
Bank; RU, resonance units; SPR, surface plasmon resonance; TABS,
TolA-binding site.
Supplementary methods and seven supplementary figures are available
with the online Supplementary Material.
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uses LPS as its primary receptor on the cell surface and
binds to it with its central receptor-binding domain ColN-R
(ColN91–183) (Johnson et al., 2014). Like ColE9 (Housden
et al., 2010, 2013) it also binds to outer membrane protein F
(OmpF) via an OmpF-binding site at the extreme N
terminus of its disordered translocation domain (T
domain), ColN-T (ColN1–90) (Johnson et al., 2013). It then
binds to TolAIII (Anderluh et al., 2003) via a TolA-binding
site (TABS) in the central region of ColN-T (ColN40–67).
Like most other colicins, ColA-R (ColA173–388) binds to a
protein receptor, the vitamin B12 uptake protein, BtuB, as its
primary receptor, and then recruits OmpF before ColA-T
(ColA1–172) binds to both TolA and TolB (Bouveret et al.,
1998; Kim et al., 2014). The pore-forming domains are sited
at the C-terminal end. In this study of TolA binding we were
thus mainly interested in the colicins’ N-terminal T domains
which contain intrinsically disordered regions.
A high-resolution X-ray structure of ColA-T53–107 in complex
with TolA329–421 is available (Li et al., 2012) and the TolA-
binding ‘box’ of ColN (ColN40–67) has been identified by
mutagenesis, NMR and bioinformatics (Anderluh et al.,
2003, 2004; Gokce et al., 2000; Hecht et al., 2008, 2009;
Raggett et al., 1998). The TolQRAB complex interacts with
other proteins of the outer membrane and inner leaflet such
as Pal, Lpp and OmpA, establishing an energy-dependent
link between the inner and outer membranes (Cascales et al.,
2000). As well as interactions with colicin T domains, TolAIII
is also known to bind the N-terminal (N1) domain of G3p
(gene-3-protein) – a minor coat protein located at the end
of the phage capsid of filamentous bacteriophage (Click &
Webster, 1997; Riechmann & Holliger, 1997). A high-reso-
lution structure of TolA295–421 in complex with G3p-N11–86
has been described by X-ray crystallography [Protein Data
Bank (PDB) ID: 1Tol] (Lubkowski et al., 1999) and NMR
(PDB ID: 1S62) (Deprez et al., 2005). In the native struc-
ture of G3p-N1-N2 (PDB ID: 2g3p) (Holliger et al., 1999),
the N1 domain binds to the N2 domain via ~30-residue
contacts and TolAIII was found to interact with the same
region (Lubkowski et al., 1999). This situation is mirrored in
ColN where the ColN-T TABS epitope binds to both ColN-
R and TolAIII (Hecht et al., 2008). Both ColN-T and G3p-N1
bind TolAIII with similar affinity, KD~1 mM (Anderluh et al.,
2004; Gokce et al., 2000; Karlsson et al., 2003; Raggett et al.,
1998).
The crystal structure of ColN has been resolved by X-ray
crystallography to 3.1 A˚ resolution (Vetter et al., 1998);
however, the T domain, a highly dynamic region, was
unresolved. It was later shown by NMR that the disordered
ColN-T is not entirely unstructured but, in an analogous
way to G3p, ColN-T TABS is associated with the rest of
Col-N (Hecht et al., 2008). Furthermore, it was shown that
ColN-T TABS binds to similar regions of TolAIII as G3p-
N1 (Hecht et al., 2009). Here, we used mutagenesis to map
the ColN-T-binding site of TolAIII. Mutants were designed
using the current X-ray structures of TolAIII in complex
with G3p-N1 (Lubkowski et al., 1999) and ColA-T (Li et al.,
2012), and previous NMR studies. These mutants were
analysed both in vitro using surface plasmon resonance
(SPR) and in vivo using whole-cell killing assays to
demonstrate a direct link between protein–protein inter-
actions and toxicity for each mutant.
METHODS
Bacterial strains, plasmids and protein purification. See supple-
mentary methods available in the online Supplementary Material.
Spot test killing assay. The activities of ColN and ColA were
assayed using the established spot test dilution assay (Pugsley &
Schnaitman, 1978). Dilutions of colicin were spotted onto a lawn
of JC207 (DTolA) E. coli cells harbouring the TolA-encoding WT
pSKL10 or mutant plasmids and incubated at 37 uC for 16 h. The
degree of complementation of the TolA deletion was taken as the
lowest concentration of colicin that produced a zone of clearance.
Liquid culture killing assay. A single colony of E. coli JC207 cells
carrying mutant or WT pSKL10 plasmid was inoculated into 5 ml
lysogeny broth (LB) containing 100 mg ampicillin ml21 [LB(amp)]
and grown overnight at 37 uC. Cells were diluted to OD600 1.7 with
LB(amp) and 5 ml added to each well of a 96-well flat-bottomed
microtitre plate containing 135 ml LB(amp) (pre-warmed to 37 uC).
These were grown at 30 uC, with 4 mm double-orbital shaking at
150 r.p.m. in a FluoStar Optima plate reader, 60 cycles of 600 s with
20 flashes per cycle, until OD600~0.4 was reached (cycle 26, 273 min).
Then, 15 ml 100 nM ColN (in LB medium) was added. This gave a
final ColN concentration of 10 nM, which was above the MIC of 0.5–
1 nM (Sharma et al., 2009). Blank wells containing LB(amp) only
were subtracted from the data. Growth curves were plotted using
SigmaPlot software and represent the means of two separate sets of
three wells. The final OD600 was taken at cycle 42 (153 min after
colicin addition) and was used to calculate the percentage killing of
ColN (see Table 1) with data normalized to 0 % killing for cells only
and 100 % killing for cells complemented with WT pSKL10.
SDS sensitivity assay. Using a method similar to that described
previously (Walburger et al., 2002), JC207 DTolA cells harbouring
pSKL10 (WT or mutant) plasmid or a pUC19 vector control were
grown to OD600 0.5 at 37 uC and then diluted 100-fold into LB(amp)
(pre-warmed to 37 uC) supplemented with 0 (LB added), 0.1, 0.5 or
1 % SDS (w/v in LB) and grown at 30 uC. The percentage of surviving
cells was calculated from the OD600 after 180 min growth from the
OD600 of the control pUC19 vector at 0 (100 % survival) and 180 min
(0 % survival).
Alkaline phosphatase activity. We used the method described by
Torriani (1966). Briefly, cells were cultured in minimal Tris medium
(pH 7.4). Single colonies of JC207 periplasmic-leaky cells and cells
complemented with WT TolA (pSKL10) or TolA mutant plasmids
were inoculated into 5 ml medium and grown for 8 h at 37 uC. An
aliquot of 1 ml was inoculated into 50 ml medium and grown
overnight at 37 uC, 180 r.p.m. to a final OD600~2.5. Cells (1 ml) were
centrifuged at 14 000 r.p.m. for 10 min to recover the extracellular
extract. Then, 600 ml was mixed with 400 ml p-nitrophenylphosphate
substrate (0.2 mg ml21 in 1 M Tris, pH 8 buffer). After a 10 min
incubation, alkaline phosphatase activity was measured by A410.
Circular dichroism (CDS) spectroscopy
Far-UV CD (250–185 nm). Samples were exchanged into 20 mM
sodium phosphate (pH 7.0) buffer using PD10 columns (GE
Healthcare) as per the manufacturer’s protocol and concentrations
were typically 0.5–0.7 mg ml21. Spectra were recorded in a 0.2 mm
path-length demountable cuvette using a Jasco-810 spectropolarimeter
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at 25 uC. Scans (buffer baseline performed under identical conditions
subtracted) are given as the differential mean residue extinction
coefficient De. The signal at 222 nm is an approximate measure of the
a-helical content (Chen & Yang, 1971).
Near-UV CD (320–250 nm). Samples, in the same buffer, were
typically 0.5 mg ml21. Spectra were recorded in a 1 cm path-length
cuvette at 25 uC. Results are given as the molar ellipticity.
Thermal denaturation. Samples in 20 mM sodium phosphate (pH 7)
buffer at a concentration of ~0.15 mg ml21 were monitored (in a
1 mm path-length cuvette) at 222 nm from 20 to 90 uC for TolAIII
constructs and at 288 nm from 25 to 95 uC for G3p-N1 constructs. The
fraction of TolAIII unfolded (fu) was calculated at x uC using:
f
V V
V V
x
u
u
n u
=
−
−
where Vu represents the far-UV CD value at 222 nm for unfolded
TolAIII (at 90 uC), Vn represents the far-UV CD value at 222 nm for
native TolAIII (at 20 uC) and Vx represents the far-UV CD value at
222 nm for TolAIII at x uC. Data were plotted using SigmaPlot
software and Tm values derived from sigmoidal fits.
Binding studies: SPR. Experiments were performed using CM5
sensor chips using a Biacore X-100 (GE Healthcare) at 25 uC. The
running buffer was HEPES-EP (10 mM HEPES, pH 7.4, 150 mM
NaCl, 3.4 mM EDTA and 0.05 %, v/v, P20 detergent). All immobi-
lizations were performed at 5 ml min21 using standard amine-
coupling carbodiimide chemistry procedures with the ligand proteins
at 10 mg ml21 in 10 mM sodium acetate (pH 4.5) buffer. TolAIII,
TolAIII K420P, TolAIII D418P and G3p-N1 V44P were immobilized at
596, 564, 550 and 423 resonance units (RU), respectively, where
1 RU~1 pg protein mm22 on the surface. For ColN-T binding to
TolAIII, an improved model fit and more accurate KD were obtained
by using a lower immobilization level of 155 RU TolAIII to eliminate
mass transport effects. In all cases, an activated/blocked flow cell 1
surface was used as the control and subtracted from the data. Analyte
proteins were exchanged into HEPES-EP buffer at concentrations
described in the text. Binding kinetics were performed at 30 ml min21
using the Kinetics Wizard (Biacore X-100 control software) and
Table 1. Strains and plasmids used to express TolA and mutants
Complementation data represent the lowest concentration able to kill JC207(DTolA) plus that plasmid on the plate assay; .10 000 nM means no
killing observed at any concentration. The percentage killing by ColN in liquid culture was normalized to 0 % killing for JC207 cells only and 100 %
killing for JC207 cells complemented with WT pSKL10. The a-helix content percentage of TolAIII296–421 was given by the signal magnitude at
222 nm compared with WT (5100 %).
Strain TolAIII mutation Complementation (nM) ColN killing (%) a-Helix in far-UV CD (%)
ColN ColA
JC207 DTolA .10 000 .10 000 0 –
JC207 (pSKL10) WT TolAIII 100 500 100 100
JC207 (PUC19) DTolA (negative control) .10 000 .10 000 14 –
JC207 (pSKL10G334A) G334A 100 500 88 –
JC207 (pSKL10D336A) D336A 100 500 100 –
JC207 (pSKL10I337A) I337A 100 500 .100 –
JC207 (pSKL10N338G) N338G 100 500 91 –
JC207 (pSKL10N339A) N339A 100 1000 76 –
JC207 (pSKL10Y340A) Y340A 5000 1000 29 66
JC207 (pSKL10A341F) A341F 100 500 59 –
JC207 (pSKL10A341R) A341R 500 500 41 –
JC207 (pSKL10G342E) G342E 100 500 66 89
JC207 (pSKL10Q343A) Q343A 100 500 63 –
JC207 (pSKL10I344D) I344D .10 000 .10 000 0 46
JC207 (pSKL10K345A) K345A 100 500 .100 –
JC207 (pSKL10S346A) S346A 100 500 96 100
JC207 (pSKL10I348D) I348D .10 000 .10 000 14 60
JC207 (pSKL10E349A) E349A 100 500 92 –
JC207 (pSKL10 I367A) I367A 500 1000 81 54
JC207 (pSKL10 L369A) L369A 500 1000 69 55
JC207 (pSKL10E381A) E381A 500 1000 92 82
JC207 (pSKL10A391E) A391E – – – 29
JC207 (pSKL10F412A) F412A 1000 1000 39 –
JC207 (pSKL10A415R) A415R 100 500 76 –
JC207 (pSKL10A415L) A415L 100 500 .100 –
JC207 (pSKL10P416E) P416E 500 500 75 –
JC207 (pSKL10D418P) D418P .10 000 0 ,0 100
JC207 (pSKL10D418V) D418V 100 500 80 116
JC207 (PSKL10F419A) F419A 1000 500 45 58
JC207 (pSKL10K420P) K420P .10 000 10 000 ,0 93
Binding of ColN, G3p and TolB to TolA
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binding analyses were performed at 10 or 30 ml min21 using manual
mode. Surfaces were regenerated by washing with 10 mM glycine
(pH 1.8) buffer. Binding models were fitted using BIAevaluation
software (v2.0.1) to simultaneously obtain association ka and disso-
ciation kd rate constants, and the equilibrium constant KD. KD was
also determined by applying a steady-state affinity model.
RESULTS
ColN-T1–90 secondary structure predictions
High-resolution structures of TolAIII in complex with ColA
and filamentous bacteriophage M13 G3p proteins (Li et al.,
2012; Lubkowski et al., 1999) show that binding occurs
through b-strand addition such that a b-strand from
one binding partner associates with a b-strand from the
other, forming an extended b-sheet structure (Remaut &
Waksman, 2006). NMR measurements showed that ColN-
T TABS40–67 folds upon binding TolAIII (Anderluh et al.,
2003) and analysis of the amino sequence by the program
PONDR (Romero et al., 1997) predicted that this region has
a high probability of being ordered (Hecht et al., 2008).
Thus, it seemed likely that ColN-T TABS forms at least one
new b-strand in order to bind TolA; to investigate this
possibility we used the structural prediction algorithms I-
TASSER (Roy et al., 2010; Zhang, 2008), TALOS (Cornilescu
et al., 1999) and Jpred (Cole et al., 2008). An I-TASSER
model of T1–90 predicted two b-strands within the TABS
(Fig. 1a, b). Although the C score of the model is low
(23.88), it is supported by TALOS and Jpred algorithm
results in the S61–H67 region (Fig. 1a). Previous alanine-
scanning mutant studies using SPR, isothermal titration
calorimetry (ITC) and fluorescence spectroscopy showed
that two regions, W44–W46 and Y62–F66, are essential for
binding TolAIII (Anderluh et al., 2003; Gokce et al., 2000)
(Fig. 1a) Furthermore, we have previously shown that
TALOS analysis of 1H–15N NMR backbone chemical shifts
(Ca, Cb, CO and N) of ColN40–76 bound to TolAIII
(a)
(b) (c)
(d)
S333
P421
ColA
box
α2
α4 α5
α3 β1
β3
β2
TABS
N40 P74K
I-TASSER
Jpred
TALOS
NS
Fig. 1. (a) Secondary structure analysis of ColN-T1–90. Structural predictions. Primary sequence of the ColN-T TABS, residues
40–74; there was no prediction of structure elsewhere. Previously reported binding to TolAIII (Anderluh et al., 2004; Gokce et al.,
2000; Raggett et al., 1998) is shown as WT binding (,10 mM) (red squares), intermediate binding (green diamonds) and no
binding (blue circles). The self-recognition region determined by NMR by Hecht et al. (2008) is highlighted in grey. Schematic
representation of the secondary structure predictions by the I-TASSER three-dimensional model (Zhang, 2008) (top line), Jpred
algorithm (Cole et al., 2008) (middle line) and TALOS prediction (Cornilescu et al., 1999) of the b-structure using the backbone
chemical shifts of the T domain bound to TolAIII (bottom line). (b) I-TASSER ribbon model of ColN-T1–90; coloured regions as in
(a). (c) Binding of ColA-T (red) and G3p-N1 (green) to TolAIII. Drawn in PyMOL (http://www.pymol.org/) using PDB ID: 3QDR
and PDB ID: 1Tol, respectively. The ColA and G3p b-strand binding regions are shown in brown and magenta, respectively.
Site of G3p-N1 V44P mutation shown in yellow. (d) Primary structure of TolAIII S333–P421. Secondary structure elements: a-
helices (red blocks) and b-strands (blue arrows). Contacts with G3p-N1, inter-atomic distances ,4.5 A˚ (yellow dots) (PDB ID:
1Tol; Lubkowski et al., 1999). Residues which showed the strongest NMR chemical shift variations (.0.55 p.p.m.) upon
binding ColN-T1–90 (Hecht et al., 2009) are shown as red dots. The ColA-binding box (Li et al., 2012) is shown. The residues
mutated in this study are shaded pink. The ColA (b2) and G3p (b3) b-strand binding regions are shown in brown and magenta,
respectively.
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predicted ColN-T residues S61–F66 (SYHITF) to fall
within the b-region of the Ramachandran plot (Hecht
et al., 2009) (Fig. 1a).
The structures of the ColA-T and G3p complexes are shown
superimposed in Fig. 1(c), and the secondary structure of
TolAIII is represented in Fig. 1(c) (taken from PDB ID: 1Tol;
Lubkowski et al., 1999). Although we used TolAIII296–421 in
this study, only residues 333–421 are shown in Fig. 1(d) as
aa 296–332 are not resolved in any published structure or
thought to be involved in interactions, and therefore were
not mutated in this study. Structural contacts with G3p-N1
are indicated by yellow circles and the ColA-binding site
(Li et al., 2012) is shown (Fig. 1d). Residues which pre-
viously showed the strongest NMR chemical shift variations
(.0.55 p.p.m.) upon binding ColN-T1–90 (Hecht et al.,
2009) are indicated by red circles and the residues mutated
in this study are shaded pink (Fig. 1d).
Defining ColN-T–TolAIII by mutagenesis
We initially selected mutation sites by studying the contacts
in the crystal structures of TolAIII complexed with G3p-N1
and ColA-T. The TolAIII G3p (PDB ID: 1Tol; Lubkowski
et al., 1999) complex shows binding to TolAIII via two
distinct regions: the first a-helix of TolAIII (a2 of full-length
TolA) and b-strand addition to b3 (Fig. 1c). Mutants were
created in these two regions. Mutations in a2 were: G334A,
D336A, I337A, N338G, N339A, Y340A, A341F/R, G342E,
Q343A, I344D, K345A, S346A, I348D and E349A; muta-
tions in b3 were: F412A, A415L/R, P416L, D418P/V, F419A
and K420P (Fig. 1d). Weitzel & Larsen (2008) have shown
that an E. coli DTolA strain can be partially complemented
by Yersinia enterocolitica TolA, regaining sensitivity to
ColA, ColK and ColE1, but not ColN. Sequence alignment
of the two TolA proteins revealed a non-conserved region
within TolA a2 and the E. coli sequence GADINNYA was
mutated to AGDISGYL to give a ‘Y. enterocolitica-like’ TolA.
A ColA TABS mutant, 375-LLDIKP-380 to AAAAKA, as
described by Li et al. (2012), was also constructed. Finally,
we targeted residues with the strongest NMR chemical
shift variations (.0.55 p.p.m.) upon binding ColN-T40–76
(Hecht et al., 2009). This resulted in the following muta-
tions: I367A, L369A, E381A, A391E, A415L and F419A.
Colicin resistance of TolA mutants
pSKL10, a plasmid expressing TolA, successfully comple-
mented E. coli JC207 DTolA cells in both liquid culture and
spot test assays, restoring both resistance to SDS and
sensitivity to ColA and ColN. The selected mutations were
made within the TolAIII region of pSKL10 and used to
complement DTolA E. coli cells. Fig. 2 shows a selection of
spot test assays and growth curves representing mutants
displaying a WT TolA phenotype (e.g. A415R, cyan), partial
phenotype (Y340A, blue; F419A, green) and complete
resistance to colicin (I344D, orange) (see Fig. S1 for the
full set of mutants). For spot test assays, the degree of
complementation conferred by pSKL10 mutant plasmids to
DTolA E. coli cells was measured as the lowest concentration
of colicin that resulted in a zone of clearance on agar plates
(Figs 2 and S1) and is given in Table 1. The resistance to both
ColN and ColA was measured, and compared with WT
pSKL10 complemented (TolA positive control) and non-
complemented JC207 cells (TolA negative control). For the
WT pSKL10 plasmid these values were 100 and 500 nM for
ColN and ColA, respectively. Most mutations within the a2
region and those highlighted as targets by NMR showed
WT-like activity. Only more structurally disrupting muta-
tions, such as I344D and I348D (Figs 2 and S1), showed
complete resistance (.10 000 nM) to both colicins. Growth
curves were measured in liquid culture to investigate the
effect of ColN in real-time. Again, most mutations displayed
a WT colicin-sensitive TolA phenotype, with I344D and
I348D showing complete resistance, and Y340A showing
a partially resistant phenotype. The ‘Y. enterocolitica’ TolA
chimera displayed a slightly greater resistance to ColN
(500 nM) than WT (100 nM), but confirmed that a2 was
not a critical site for ColN (Fig. S2). The ColA TABS mutant
was resistant to ColA, but sensitive to ColN, indicating that
the two colicins bound to TolA at different sites (Fig. S2).
Structural characterization of TolAIII mutants
We made the same mutations in a plasmid that expressed
only TolAIII296–421, a well-characterized soluble domain
truncate lacking the long helices of TolAI–II, and used far-
UV CD spectroscopy to measure the secondary structure
content. A selection of spectra is presented in Fig. 2(c).
The WT TolAIII gave a typical ab spectrum characterized
by minima at 222 and 208 nm, and was comparable
with previously published data (Anderluh et al., 2004;
Derouiche et al., 1999). I344D and I348D (data not shown)
showed spectra typical of an unfolded structure with
negative maxima ,200 nm, which explained their inability
to complement the DTolA mutation. Some mutations did
not affect the structure, whilst others showed limited loss
of a-helical content compared with the WT protein (Fig.
2c; Table 1). We believe this was due to a partial or full
collapse of the a2 or a4 helix.
Testing the hypothesis that ColN-T binds TolAIII
via b-strand complementation at b3
The previous NMR data (Hecht et al., 2009) and secondary
structure predictions (Fig. 1) indicated that the binding
region ColN-T residues S61–F66 (SYHITF) form a b-
strand upon binding to TolA. Mutating the (b-strand
addition) ColA-binding site on the TolA mutant displayed
ColA but not ColN resistance in both spot test (Fig. S2)
and liquid culture (data not shown) assays, indicating that
this was not the binding site of ColN. As G3p-N1 binds to
b3 on the opposite side of TolAIII, via b-strand addition,
and NMR data indicated a common binding site to G3p
(Hecht et al., 2009), we then selected this strand for mutation;
however, side-chains play a limited role in b-strand addition
Binding of ColN, G3p and TolB to TolA
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(Remaut & Waksman, 2006). In the PDB ID: 1Tol structure
(Lubkowski et al., 1999), two TolAIII b3 residues, D418 and
K420, form critical backbone amide–carbonyl hydrogen
bonds to G3p-N1 to stabilize the b-sheet interaction between
the two proteins. We removed these amide protons by
mutation to proline residues which lack the amide protons
required for hydrogen bond donation and can only accept
hydrogen bonds via the remaining carbonyls. Thus, each
proline mutation removed one backbone hydrogen bond
which might otherwise stabilize the b-strand addition. These
mutations were modelled in the known TolA structure and,
following a simple energy minimization, showed, as expected,
that prolines had minimal influence on the b-strand backbone
conformation (Figs 3a, b). D418V was used as a positive
control mutant as valine is a strong b-strand former, can form
hydrogen bonds and is one of the ‘allowed’ residues at this
position based on the screening work of Karlsson et al. (2006).
They found that only residues A, V, G and E were both
resistant to SDS and sensitive to phage infection.
All three mutants had near WT far-UV CD spectra (Fig. 3c),
although the proline mutations did cause a shift of the
spectra minima towards 200 nm, which may indicate a small
degree of unfolding compared with WT. The structural
integrity was also determined by thermal denaturation up
to 90 uC using far-UV CD at 222 nm (Fig. 3c, inset). A
cooperative unfolding curve was observed in all cases and
used to calculate the transition midpoint temperatures (Tm)
(Fig. 3d). The WT TolAIII had a Tm of 62.4 uC, as expected
(Anderluh et al., 2004). D418P and K420P showed coope-
rative unfolding curves with reduced Tm values of 52.9 and
50.3 uC, respectively. Interestingly, the D418V mutant
showed both an increased amount of secondary structure,
indicated by a more negative minima at 222–208 nm in the
far-UV CD, and a higher Tm than WT (64.1 uC).
Spot test assays (Fig. 3e) and liquid culture killing assays
(Fig. S1) showed D418P and K420P were resistant to both
ColN and ColA, whereas D418V was as sensitive as WT
TolA. Furthermore, D418P and K420P were sensitive to
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Concentrations of 10, 5, 1, 0.5, 0.1 and 0 mM ColN (left) or ColA (right) (in 50 mM sodium phosphate, pH 7.5, 300 mM NaCl)
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0.1 % SDS, whilst WT and D418V were not (Figs 3d and
S3). This agreed with the known phenotype of mutations
within the Tol–Pal system (TolA, TolB, TolQ, TolR and
Pal) which caused cells to be hypersensitive to detergents
due to disruption of the cell envelope structural inte-
grity (Davies & Reeves, 1975). Finally, both TolA proline
mutants were shown to be resistant to ColE9 (Fig. S4),
which binds directly to TolB only (Bonsor et al., 2009), and
then is bound to TolA via the subsequent interaction of
TolB with TolA (Zhang et al., 2010). It is worth noting that
this region in Y. enterocolitica has the sequence VKFPQ
instead of the E. coli DFKP, which may allow TolA binding,
but not ColN (Weitzel & Larsen, 2008).
Neither ColN-T nor G3p-N1 binds to TolAIII proline
mutants
For SPR experiments, TolAIII, D418P and K420P were
immobilized on CM5 sensor chips (~550 RU) before
ColN-T and G3p-N1 (0.2–50 mM) were injected over the
surface (Table 2). Duplicate injections were performed and
the signal from a reference (activated/blocked) blank
surface was subtracted from each dataset. Our previous
work, carried out using glutathione S-transferase (GST)–
ColN-T fusions binding to immobilized TolAIII, fitted to a
two-site model with KD50.85 and 0.19 mM for GSTN40
(T domain residues 40–90). In the same study, the results
with immobilized GST fusions binding soluble TolAII–III
fitted to a one-site model with KD50.94 mM (Gokce et al.,
2000). Thus, the second site was possibly an artefact of
TolA immobilization. In the current study, a heterogen-
eous ligand model fit gave two sites with KD
153.0 mM and
KD
254 nM. The KD
1 is similar to the KD obtained when
applying steady-state affinity fitting (1.8 mM) (Fig. S5), a
global measure of affinity taking in contributions from
both sites, and this is comparable with the published ITC
(1 mM) (Raggett et al., 1998), SPR (1.25 mM) (Anderluh
et al., 2004) and stopped flow fluorescence (2.3 mM)
(Gokce et al., 2000) data. Crucially, no binding to either of
the proline mutants occurred. For G3p-N1, we initially
followed the previous work of Karlsson et al. (2003)
immobilizing ~950 RU TolAIII on the chip surface, which
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gave a similar KD to the published value (~1 mM);
however, the fits were poor due to mass transport effects
as indicated by high deviation of the residuals plot and a
high x2 (198 RU2). Using a lower immobilization level of
550 RU, better fits (x250.574) were obtained and a 1 : 1
Langmuir binding fit gave a KD of 14.9 mM (Fig. S5). G3p-
N1 displayed very fast kon (2.056610
4 s21) and koff
(0.307 s21) rates. Hence, steady-state affinity is the most
accurate measure of KD, which gave 11.9 mM. No binding
was seen by G3p-N1 to either of the proline mutants (Fig. 4).
G3p-N1 V44 is in the TolAIII-binding site
V44 of G3p-N1 forms two hydrogen bonds with b3 during
the b-strand addition to TolAIII. We mutated this residue
to proline to remove one hydrogen bond by removal of the
V44 amide proton. Far-UV and near-UV CD spectroscopy
showed that the V44P mutant had a similar fold to the WT
protein (Fig. S6), and at 288 nm a cooperative thermal
unfolding with Tm 49.6 uC was observed (Fig. S6, inset).
The WT G3p-N1 protein had a Tm of 60.1 uC, similar to
the published Tm (59.8 uC) calculated from the 230 nm
Table 2. SPR data for the interaction of ColN-T, G3p-N1 and G3p-N1 V44P with TolAIII and b3 mutants.
No binding was noted for G3p-N1 or ColN-T1–90 on TolAIII D418P or K420P surfaces. No binding was observed for TolAIII versus G3p-N1 V44P.
Ligand Analyte Binding fits Steady-state
affinity KD
(mM)ka
1 (M”1 s”1) kd
1 (s”1) ka
2 (M”1 s”1) kd
2 (s”1) KD
1 (mM) KD
2 (mM)
TolAIII G3p-sN1 2.06±0.02610
4 0.31±0.002 – – 15 – 11.9±0.1
TolAIII ColN-T 2.22±0.05610
4 6.7±0.0761022 9.67±0.556104 4.0±0.0461023 3 0 1.8±0.2
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Fig. 4. Biacore binding data of ColN-T, ColA-T, G3p-N1 and TolB to WT TolAIII, D418P and K420P. Around 500 RU of
either (a) TolAIII276–421WT, (b) D418P or (c) K420P protein was immobilized on a CM5 sensor chip using amine coupling.
ColN-T (solid line), ColA-T (dotted line) or G3p-N1 (dashed line) (5 mM) were injected over each surface at 30 ml min”1 for
120 s followed by regeneration with 10 mM glycine, pH 1.8. (d) TolB (10 mM in HEPES-EP buffer) was injected over the
immobilized WT and TolAIII mutant surfaces described above at 10 ml min
”1 for 180 s followed by regeneration with 10 mM
glycine, pH 1.8. Only the WT surface bound TolB. (e) WT and mutants of TolB (5 mM) were injected over immobilized TolAIII.
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transition in far-UV CD by Martin & Schmid (2003). For
SPR, TolAIII was immobilized on a CM5 sensor chip
(~550 RU) and varying concentrations of V44P, up to
250 mM, injected over the surface. A small amount of
binding was noted .200 mM (~10 RU), but this was
confirmed as non-specific by reversing the ligand/analyte
and immobilizing G3p-N1 V44P on the chip surface
(488 RU) and passing over TolAIII (to 250 mM), where no
binding occurred.
ColA-T binds to TolAIII D418P and K420P. The
interactions of isolated ColN-T, ColA-T and G3p-N1
domains with TolAIII, D418P and K420P were compared
using SPR. Comparable levels of each TolA version were
immobilized to the CM5 chip surface. ColN-T, ColA-T and
G3p-N1 all bound to the WT TolAIII surface (Fig. 4a), but
only ColA-T bound to the mutant surface, with ColN-T
and G3p-N1 showing no binding (Fig. 4b, c), even at
concentrations up to 250 mM (data not shown).
TolA D418 and K420 are in the TolB-binding site.
Although ColA-T can bind to TolAIII D418P and TolAIII
K420P (Figs 4b, c), no killing by ColA was seen in spot test
assays (Fig. 3e). We believed that this was due to the
disruption of TolA–TolB interactions by these mutants. To
test this, 10 mM TolB was injected over TolAIII WT and
mutant surfaces in SPR experiments. Binding was seen on
the WT TolAIII surface, but not to either of the mutants
(Fig. 4d). As the TolA–TolB interaction was thought to
be important for Tol function, we tested the outer
membrane integrity of E. coli cells expressing the TolA
point mutants. Extracellular levels of alkaline phosphatase,
which is normally trapped in the periplasm, were measured
for JC207 DTolA cells only and cells complemented with
WT TolAIII, D418P and K420P plasmids. Baseline alkaline
phosphatase activity in culture supernatants, measured as
OD410, was 0.23, whereas the value for JC207 DTolA cells
was 0.72. For cells complemented with the WT plasmid
it was 0.24, but TolAIII D418P and K420P gave values of
0.67 and 0.69, respectively. Furthermore, WT complemented
cells released approximately one-fifth of the amount of
extracellular proteins visible from mutant cultures on 10 %
SDS-PAGE (data not shown). Thus, the proline point
mutants destabilized the outer membrane and created a clear
tol phenotype.
TABS on TolB
A TABS has been proposed in the disordered 12 N-
terminal residues of TolB (Bonsor et al., 2009; Carr et al.,
2000; Walburger et al., 2002), which thus could also
engage in b-strand addition, whilst Dubuisson et al. (2002)
identified D120 as also being potentially involved in
binding. Here, we used alignments of the amino acid
sequences of TolB, ColN and G3p-N1 to identify possible
TolAIII-binding motifs (Fig. S4). First, TolB shares the
sequence DGSY (109–112) with the core of the ColN-T
TABS (59–62) and VVV (99–101) with residues 61–63 of
G3p which are central to its TABS b-strand (Fig. S4). To
test if these revealed shared binding sequences, we made
the following mutations in TolB: DGSY-AGAA, VVV-AAA
and V101P (to inhibit backbone hydrogen bonds). DGSY-
AGAA and V101P showed a WT far-UV CD spectrum with
VVV-AAA showing a more unfolded spectrum (Fig. S7A).
Cooperative unfolding curves at 217 nm gave Tm550.9,
52.8 and 50.8 uC for DGSY-AGAA, V101P and VVV-AAA,
respectively (data not shown). The Tm for the WT TolB
was 55.4 uC. DGSY-AGAA and V101P mutants displayed
WT near-UV CD (Fig. S7B).
TolAIII (645 RU) was immobilized on a CM5 chip and
5 mM WT TolB, DGSY-AGAA, V101P or VVV-AAA passed
over the surface (Fig. 4e). The 1 : 1 Langmuir binding
fits were obtained as described previously (Table 3), giving
a KD of 37.3 mM for WT TolB binding to TolAIII, in
agreement with the published data of 40 mM obtained
using ITC (Bonsor et al., 2009). The DGSY substitution
was comparable with WT, but TolB VVV and V101P
mutants did not bind TolA.
DISCUSSION
ColN-T–TolAIII binding
Previous studies (Anderluh et al., 2003, 2004; Gokce et al.,
2000; Hecht et al., 2009; Raggett et al., 1998) have defined
the TABS of ColN and the structural changes involved
upon binding. However, no high-resolution structure is yet
available for this complex and the ColN-binding site of
TolAIII is unknown. TolA has been identified as a trans-
locator for several colicins and phage, with little sequence
or structural identity between the proteins involved (Hecht
Table 3. SPR data for the interaction of TolAIII with TolB WT and mutants
Ligand Analyte Binding fits Steady-state affinity KD
(mM)
ka (M
”1 s”1) kd (s
”1) KD (mM)
TolAIII TolB 8.27±0.12610
3 0.3±0.004 37 43.2±9.0
DGSY TolAIII 2.71±0.05610
3 0.10±0.002 39 48.3±4.5
TolAIII V101P 4.02±0.21610
3 0.59±0.01 146 –
VVV-AAA TolAIII 0.33±0.006610
3 0.07±0.001 215 –
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et al., 2009), and we showed that ColN does not bind to
TolAIII at the recently identified ColA-binding site (Li et al.,
2012). It has previously been shown by NMR that the
proteins G3p-N1, of filamentous bacteriophage M13, and
ColN-T interact with the same region of TolAIII (Hecht
et al., 2009). Thus, we selected mutant targets using the
structure of TolAIII complexed with G3p-N1 (PDB ID:
1Tol; Lubkowski et al., 1999) and our previous NMR data
(Hecht et al., 2009). Single point mutations along the entire
length of TolA a2, and which preserved the native
structure, did not affect the toxicity of ColN and ColA.
Residues identified by NMR chemical shift changes of
.0.55 p.p.m. upon ColN binding (Hecht et al., 2009) were
mutated to alanines, but showed little resistance to colicin.
Hence, these must be involved in subtle structural
rearrangement of TolAIII upon binding ColN-T, but the
amino acid side-chains are not part of the binding site. The
importance of this distinction will become clear below.
TolAIII b-strand addition promiscuity
G3p–TolA (Deprez et al., 2005; Lubkowski et al., 1999),
ColA–TolA (Li et al., 2012) and a complex of TolAIII of
Vibrio cholerae with the N-terminal CTXØ minor coat
protein pIII of F bacteriophage (CTXØpIII–TolA) (Ford
et al., 2012) are all examples of b-strand addition-type
mechanisms (Remaut & Waksman, 2006). As only weak
sequence constraints determine the b-strand propensity of
peptides, promiscuity of binding partners is possible and
binders may be either folded or disordered domains. Secondary
structure predictions (Cole et al., 2008; Cornilescu et al.,
1999; Roy et al., 2010; Zhang, 2008) all suggest that the ColN
sequence Y62–H67 adopts a b conformation and, in our
previous NMR study, the binding of G3p caused large
15N–1H-heteronuclear single quantum coherence chemical
shift changes in b2 and b3 of TolA. These were largely
imitated by ColN-T binding with even larger effects on b3
(Hecht et al., 2009).
Deprez et al. (2005) described a ‘stretching’ of the TolAIII
b-sheet (b2+b1+b3) upon G3p-N1 binding; in particular,
b3 is extended and a ‘bulge’ present in b2 disappears. The
PDB ID: 1Tol structure shows that residue V44 of G3p
contributes to backbone hydrogen bonding in b-addition
and we made a G3p V44P mutant to remove the critical
amide proton. This mutant did not bind TolAIII.
Two TolAIII residues, D418 and K420 (Figs 1 and 3), are
similarly involved in the hydrogen-bonding network with
G3p-N1. D418 does show a chemical shift upon ColN-T
binding, but was below our 0.55 p.p.m. cutoff for the
initial round of mutagenesis, and K420 was not assigned in
the NMR spectrum due to its flexibility at the terminus of
the protein. Proline mutants should not strongly disrupt
the b structure (Chou & Fasman, 1974) and are the clearest
way to test for b-strand addition (Fig. 3) (Joseph et al.,
2013). Both mutations showed small structural changes
by CD and still bound the ColA-T domain in a SPR assay,
but showed clear ColN-resistant phenotypes. These results
confirm that ColN-T1–90 binds via a b-strand addition to
TolAIII b3 with ColN-T contributing at least one b-strand
from within the TolA box, probably residues Y62–H66.
Interestingly, Karlsson et al. (2006) performed a random
mutagenesis screen on this region of TolAIII, A415–K420,
and proline mutants at these positions were screened out as
being phage resistant. Their work shows that sequence
conservation in this area is second to structural preference
with at least one of the b-promoting WT residues (L417,
D418 or K420) being retained or replaced with another
strong b-former (such as V, L, M and I). It would be
interesting to challenge these libraries with ColN and ColA.
Importance of D418P and K420P mutations in
ColA and ColE9 killing
Although the ColN-T- and ColA-T-binding sites are on
opposite sides of the TolAIII structure, and ColA-T also
binds the mutant proteins, the proline mutations within
TolAIII b3 still cause resistance to ColA. ColA clearly has a
different mechanism of translocation to that of ColN and it
has been proposed that ColA-T interacts first with TolB in
the periplasm via its low-affinity TolB box, followed by
high-affinity interaction with TolA (Zhang et al., 2010).
TolA has been shown to interact with TolB in vitro by ITC
(KD~40 mM) (Bonsor et al., 2009), cross-linking and yeast
two-hybrid experiments (Walburger et al., 2002), and this
interaction is enhanced (KD~13 mM) when ColE9 binds to
TolB (Bonsor et al., 2009).
However, the interpretation of ColA and ColE9 activity is
complicated by the discovery that these point mutations
give cells a DTol phenotype including sensitivity to SDS.
This implies a disruption of the cell envelope due to the
inhibition of the TolA–TolB complex. We used an alkaline
phosphatase assay (Lazzaroni & Portalier, 1981; Torriani,
1966) to show that periplasmic alkaline phosphatase,
which is larger (79 kDa) than TolB (47 kDa), leaches into
the extracellular medium of DTolA periplasmic-leaky
cells (JC207). Crucially, similar amounts of alkaline phos-
phatase leached out from TolAIII D418 and K420 mutants.
As we cannot determine any effects on the TolB–Pal
interaction, we cannot thus rule out that the inability of
ColA and ColE9 to kill these mutants may be due to very
low levels of periplasmic TolB rather than a need for a
TolA–TolB interaction to maintain the ColA–TolB–TolAIII
or ColE9–TolB–TolAIII complex.
The two different binding sites for TolB and ColA-T on
TolAIII support the formation in vivo of a heterotrimeric
complex which has been observed by gel filtration in vitro
(Hecht et al., 2010), but it is not clear if a direct TolB–TolA
interaction is required for the toxic activity of ColA, as it is
for ColE9, or whether the bifunctional ColA-T cross-links
the complex. The disordered extreme N terminus of TolB
has been shown to bind TolAIII and the NMR spectrum of
a TolAIII–TolB
1–13 complex resembles that of a TolAIII–
ColN-T complex (Li et al., 2012). Thus it is likely that TolB
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and ColN-T bind via a similar b-strand addition
mechanism.
The combined data for three different Group A (Tol-
dependent) colicins give an insight into their use of the
same Tol proteins in fundamentally different ways, but for
apparently the same purpose. ColE9 binds only TolB, but
by doing so stabilizes the TolA–TolB complex (Bonsor
et al., 2009). ColA requires direct interaction with both
TolA and TolB, but it is not clear if a direct TolA–TolB
complex is required (Penfold et al., 2012). Finally, ColN is
unique in not requiring TolB and binds TolA at the precise
site where TolB would bind. ColN consistently displays
minimalistic behaviour as demonstrated by its small size,
LPS receptor (Johnson et al., 2014), single protein receptor
(Clifton et al., 2012; Johnson et al., 2013) and lack of TolB
dependence. This simplicity makes ColN unique in colicin
biology, and the disruption of TolA–TolB may be relevant
to our recent discovery that ColN-T alone can target and
kill E. coli (Johnson et al., 2013).
ACKNOWLEDGEMENTS
We thank Chris Penfold and Nick Housden for their kind gifts of
ColA-T proteins and ColE9, respectively. We gratefully acknowledge
Chris Johnson and David Chalton for their reading of the manuscript.
This work was supported by The Wellcome Trust (grants 080342 and
093581).
REFERENCES
Abergel, C., Bouveret, E., Claverie, J. M., Brown, K., Rigal, A.,
Lazdunski, C. & Be´ne´detti, H. (1999). Structure of the Escherichia coli
TolB protein determined by MAD methods at 1.95 A resolution.
Structure 7, 1291–1300.
Anderluh, G., Hong, Q., Boetzel, R., MacDonald, C., Moore, G. R.,
Virden, R. & Lakey, J. H. (2003). Concerted folding and binding of a
flexible colicin domain to its periplasmic receptor TolA. J Biol Chem
278, 21860–21868.
Anderluh, G., Go¨kc¸e, I. & Lakey, J. H. (2004). A natively unfolded
toxin domain uses its receptor as a folding template. J Biol Chem 279,
22002–22009.
Baty, D., Pattus, F., Parker, M., Benedetti, H., Frenette, M.,
Bourdineaud, J. P., Cavard, D., Knibiehler, M. & Lazdunski, C.
(1990). Uptake across the cell envelope and insertion into the inner
membrane of ion channel-forming colicins in E coli. Biochimie 72,
123–130.
Bonsor, D. A., Hecht, O., Vankemmelbeke, M., Sharma, A., Krachler,
A. M., Housden, N. G., Lilly, K. J., James, R., Moore, G. R. &
Kleanthous, C. (2009). Allosteric b-propeller signalling in TolB and
its manipulation by translocating colicins. EMBO J 28, 2846–2857.
Bouveret, E., Derouiche, R., Rigal, A., Lloube`s, R., Lazdunski, C. &
Be´ne´detti, H. (1995). Peptidoglycan-associated lipoprotein-TolB
interaction. A possible key to explaining the formation of contact
sites between the inner and outer membranes of Escherichia coli. J Biol
Chem 270, 11071–11077.
Bouveret, E., Rigal, A., Lazdunski, C. & Be´ne´detti, H. (1998). Distinct
regions of the colicin A translocation domain are involved in the
interaction with TolA and TolB proteins upon import into Escherichia
coli. Mol Microbiol 27, 143–157.
Carr, S., Penfold, C. N., Bamford, V., James, R. & Hemmings, A. M.
(2000). The structure of TolB, an essential component of the tol-
dependent translocation system, and its protein-protein interaction
with the translocation domain of colicin E9. Structure 8, 57–66.
Cascales, E., Gavioli, M., Sturgis, J. N. & Lloube`s, R. (2000). Proton
motive force drives the interaction of the inner membrane TolA and
outer membrane pal proteins in Escherichia coli. Mol Microbiol 38,
904–915.
Cascales, E., Buchanan, S. K., Duche´, D., Kleanthous, C., Lloube`s,
R., Postle, K., Riley, M., Slatin, S. & Cavard, D. (2007). Colicin biology.
Microbiol Mol Biol Rev 71, 158–229.
Chen, Y. H. & Yang, J. T. (1971). A new approach to the calculation of
secondary structures of globular proteins by optical rotatory dispersion
and circular dichroism. Biochem Biophys Res Commun 44, 1285–1291.
Chou, P. Y. & Fasman, G. D. (1974). Conformational parameters for
amino acids in helical, b-sheet, and random coil regions calculated
from proteins. Biochemistry 13, 211–222.
Click, E. M. & Webster, R. E. (1997). Filamentous phage infection:
required interactions with the TolA protein. J Bacteriol 179, 6464–
6471.
Click, E. M. & Webster, R. E. (1998). The TolQRA proteins are
required for membrane insertion of the major capsid protein of the
filamentous phage f1 during infection. J Bacteriol 180, 1723–1728.
Clifton, L. A., Johnson, C. L., Solovyova, A. S., Callow, P., Weiss, K. L.,
Ridley, H., Le Brun, A. P., Kinane, C. J., Webster, J. R. P. & other
authors (2012). Low resolution structure and dynamics of a colicin-
receptor complex determined by neutron scattering. J Biol Chem 287,
337–346.
Cole, C., Barber, J. D. & Barton, G. J. (2008). The Jpred 3 secondary
structure prediction server. Nucleic Acids Res 36 (Web Server), W197-
201.
Cornilescu, G., Delaglio, F. & Bax, A. (1999). Protein backbone angle
restraints from searching a database for chemical shift and sequence
homology. J Biomol NMR 13, 289–302.
Davies, J. K. & Reeves, P. (1975). Genetics of resistance to colicins in
Escherichia coli K-12: cross-resistance among colicins of group A.
J Bacteriol 123, 102–117.
Deprez, C., Lloube`s, R., Gavioli, M., Marion, D., Guerlesquin, F. &
Blanchard, L. (2005). Solution structure of the E.coli TolA C-terminal
domain reveals conformational changes upon binding to the phage
g3p N-terminal domain. J Mol Biol 346, 1047–1057.
Derouiche, R., Be´ne´detti, H., Lazzaroni, J. C., Lazdunski, C. &
Lloube`s, R. (1995). Protein complex within Escherichia coli inner
membrane. TolA N-terminal domain interacts with TolQ and TolR
proteins. J Biol Chem 270, 11078–11084.
Derouiche, R., Lloube`s, R., Sasso, S., Bouteille, H., Oughideni, R.,
Lazdunski, C. & Loret, E. (1999). Circular dichroism and molecular
modeling of the E. coli TolA periplasmic domains. Biospectroscopy 5,
189–198.
Dubuisson, J. F., Vianney, A. & Lazzaroni, J. C. (2002). Mutational
analysis of the TolA C-terminal domain of Escherichia coli and genetic
evidence for an interaction between TolA and TolB. J Bacteriol 184,
4620–4625.
Fognini-Lefebvre, N., Lazzaroni, J. C. & Portalier, R. (1987). tolA, tolB
and excC, three cistrons involved in the control of pleiotropic release
of periplasmic proteins by Escherichia coli K12. Mol Gen Genet 209,
391–395.
Ford, C. G., Kolappan, S., Phan, H. T. H., Waldor, M. K., Winther-
Larsen, H. C. & Craig, L. (2012). Crystal structures of a CTXphi pIII
domain unbound and in complex with a Vibrio cholerae TolA domain
reveal novel interaction interfaces. J Biol Chem 287, 36258–36272.
Binding of ColN, G3p and TolB to TolA
http://mic.sgmjournals.org 513
Downloaded from www.sgmjournals.org by
IP:  128.240.229.72
On: Mon, 29 Jun 2015 11:20:59
Gerding, M. A., Ogata, Y., Pecora, N. D., Niki, H. & de Boer, P. A. J.
(2007). The trans-envelope Tol-Pal complex is part of the cell division
machinery and required for proper outer-membrane invagination
during cell constriction in E. coli. Mol Microbiol 63, 1008–1025.
Gokce, I., Raggett, E. M., Hong, Q., Virden, R., Cooper, A. & Lakey,
J. H. (2000). The TolA-recognition site of colicin N. ITC, SPR and
stopped-flow fluorescence define a crucial 27-residue segment. J Mol
Biol 304, 621–632.
Grinter, R., Josts, I., Zeth, K., Roszak, A. W., McCaughey, L. C.,
Cogdell, R. J., Milner, J. J., Kelly, S. M., Byron, O. & Walker, D. (2014).
Structure of the atypical bacteriocin pectocin M2 implies a novel
mechanism of protein uptake. Mol Microbiol 93, 234–246.
Hecht, O., Ridley, H., Boetzel, R., Lewin, A., Cull, N., Chalton, D. A.,
Lakey, J. H. & Moore, G. R. (2008). Self-recognition by an intrinsically
disordered protein. FEBS Lett 582, 2673–2677.
Hecht, O., Ridley, H., Lakey, J. H. & Moore, G. R. (2009). A common
interaction for the entry of colicin N and filamentous phage into
Escherichia coli. J Mol Biol 388, 880–893.
Hecht, O., Zhang, Y., Li, C., Penfold, C. N., James, R. & Moore, G. R.
(2010). Characterisation of the interaction of colicin A with its co-
receptor TolA. FEBS Lett 584, 2249–2252.
Holliger, P., Riechmann, L. & Williams, R. L. (1999). Crystal structure
of the two N-terminal domains of g3p from filamentous phage fd at
1.9 A: evidence for conformational lability. J Mol Biol 288, 649–
657.
Housden, N. G., Wojdyla, J. A., Korczynska, J., Grishkovskaya, I.,
Kirkpatrick, N., Brzozowski, A. M. & Kleanthous, C. (2010). Directed
epitope delivery across the Escherichia coli outer membrane through
the porin OmpF. Proc Natl Acad Sci U S A 107, 21412–21417.
Housden, N. G., Hopper, J. T. S., Lukoyanova, N., Rodriguez-Larrea,
D., Wojdyla, J. A., Klein, A., Kaminska, R., Bayley, H., Saibil, H. R. &
other authors (2013). Intrinsically disordered protein threads
through the bacterial outer-membrane porin OmpF. Science 340,
1570–1574.
Jakes, K. S. (2014). Daring to be different: colicin N finds another
way. Mol Microbiol 92, 435–439.
Johnson, C. L., Ridley, H., Pengelly, R. J., Salleh, M. Z. & Lakey, J. H.
(2013). The unstructured domain of colicin N kills Escherichia coli.
Mol Microbiol 89, 84–95.
Johnson, C. L., Ridley, H., Marchetti, R., Silipo, A., Griffin, D. C.,
Crawford, L., Bonev, B., Molinaro, A. & Lakey, J. H. (2014). The
antibacterial toxin colicin N binds to the inner core of lipopoly-
saccharide and close to its translocator protein. Mol Microbiol 92,
440–452.
Joseph, P. R. B., Poluri, K. M., Gangavarapu, P., Rajagopalan, L.,
Raghuwanshi, S., Richardson, R. M., Garofalo, R. P. & Rajarathnam,
K. (2013). Proline substitution of dimer interface b-strand residues as
a strategy for the design of functional monomeric proteins. Biophys J
105, 1491–1501.
Karlsson, F., Borrebaeck, C. A. K., Nilsson, N. & Malmborg-Hager,
A. C. (2003). The mechanism of bacterial infection by filamentous
phages involves molecular interactions between TolA and phage
protein 3 domains. J Bacteriol 185, 2628–2634.
Karlsson, F., Malmborg-Hager, A. C. & Borrebaeck, C. A. K. (2006).
Escherichia coli TolA tolerates multiple amino-acid substitutions
as revealed by screening randomized variants for membrane integ-
rity and phage receptor function. FEMS Microbiol Lett 259, 81–
88.
Kim, Y. C., Tarr, A. W. & Penfold, C. N. (2014). Colicin import into E.
coli cells: a model system for insights into the import mechanisms of
bacteriocins. Biochim Biophys Acta 1843, 1717–1731.
Kleanthous, C. (2010). Swimming against the tide: progress and
challenges in our understanding of colicin translocation. Nat Rev
Microbiol 8, 843–848.
Lazzaroni, J. C. & Portalier, R. C. (1981). Genetic and biochemical
characterization of periplasmic-leaky mutants of Escherichia coli K-12.
J Bacteriol 145, 1351–1358.
Levengood, S. K. & Webster, R. E. (1989). Nucleotide sequences of
the tolA and tolB genes and localization of their products,
components of a multistep translocation system in Escherichia coli.
J Bacteriol 171, 6600–6609.
Li, C., Zhang, Y., Vankemmelbeke, M., Hecht, O., Aleanizy, F. S.,
Macdonald, C., Moore, G. R., James, R. & Penfold, C. N. (2012).
Structural evidence that colicin A protein binds to a novel binding site
of TolA protein in Escherichia coli periplasm. J Biol Chem 287, 19048–
19057.
Lubkowski, J., Hennecke, F., Plu¨ckthun, A. & Wlodawer, A. (1999).
Filamentous phage infection: crystal structure of g3p in complex with
its coreceptor, the C-terminal domain of TolA. Structure 7, 711–
722.
Martin, A. & Schmid, F. X. (2003). Evolutionary stabilization of the
gene-3-protein of phage fd reveals the principles that govern the
thermodynamic stability of two-domain proteins. J Mol Biol 328,
863–875.
Penfold, C. N., Li, C., Zhang, Y., Vankemmelbeke, M. & James, R.
(2012). Colicin A binds to a novel binding site of TolA in the
Escherichia coli periplasm. Biochem Soc Trans 40, 1469–1474.
Pugsley, A. P. & Schnaitman, C. A. (1978). Identification of three
genes controlling production of new outer membrane pore proteins
in Escherichia coli K-12. J Bacteriol 135, 1118–1129.
Raggett, E. M., Bainbridge, G., Evans, L. J. E., Cooper, A. & Lakey, J. H.
(1998). Discovery of critical Tol A-binding residues in the bactericidal
toxin colicin N: a biophysical approach. Mol Microbiol 28, 1335–
1343.
Remaut, H. & Waksman, G. (2006). Protein-protein interaction
through b-strand addition. Trends Biochem Sci 31, 436–444.
Riechmann, L. & Holliger, P. (1997). The C-terminal domain of TolA
is the coreceptor for filamentous phage infection of E. coli. Cell 90,
351–360.
Romero, P., Obradovic, Z., Kissinger, C., Villafranca, J. E. & Dunker,
A. K. (1997). Identifying disordered regions in proteins from amino
acid sequence. In Proceedings of the International Conference on Neural
Networks, vol. 1, pp. 90–95. New York: IEEE.
Roy, A., Kucukural, A. & Zhang, Y. (2010). I-TASSER: a unified
platform for automated protein structure and function prediction.
Nat Protoc 5, 725–738.
Schendel, S. L., Click, E. M., Webster, R. E. & Cramer, W. A. (1997).
The TolA protein interacts with colicin E1 differently than with other
group A colicins. J Bacteriol 179, 3683–3690.
Sharma, O., Datsenko, K. A., Ess, S. C., Zhalnina, M. V., Wanner,
B. L. & Cramer, W. A. (2009). Genome-wide screens: novel
mechanisms in colicin import and cytotoxicity. Mol Microbiol 73,
571–585.
Torriani, A. (1966). Alkaline phosphatase from Escherichia coli.
In Procedures in Nucleic Acid Research, pp. 224–235. Edited by
G. L. Cantoni & D. R. Davies. New York: Harper & Row.
Vetter, I. R., Parker, M. W., Tucker, A. D., Lakey, J. H., Pattus, F. &
Tsernoglou, D. (1998). Crystal structure of a colicin N fragment
suggests a model for toxicity. Structure 6, 863–874.
Walburger, A., Lazdunski, C. & Corda, Y. (2002). The Tol/Pal system
function requires an interaction between the C-terminal domain of
TolA and the N-terminal domain of TolB. Mol Microbiol 44, 695–708.
H. Ridley and J. H. Lakey
514 Microbiology 161
Downloaded from www.sgmjournals.org by
IP:  128.240.229.72
On: Mon, 29 Jun 2015 11:20:59
Webster, R. E. (1991). The tol gene products and the import of
macromolecules into Escherichia coli. Mol Microbiol 5, 1005–1011.
Weitzel, A. C. & Larsen, R. A. (2008). Differential complementation of
DeltatolA Escherichia coli by a Yersinia enterocolitica TolA homo-
logue. FEMS Microbiol Lett 282, 81–88.
Zhang, Y. (2008). I-TASSER server for protein 3D structure prediction.
BMC Bioinformatics 9, 40.
Zhang, Y., Li, C., Vankemmelbeke, M. N., Bardelang, P., Paoli, M.,
Penfold, C. N. & James, R. (2010). The crystal structure of the TolB
box of colicin A in complex with TolB reveals important differences
in the recruitment of the common TolB translocation portal used by
group A colicins. Mol Microbiol 75, 623–636.
Edited by: G. Unden
Binding of ColN, G3p and TolB to TolA
http://mic.sgmjournals.org 515
